Blockchain for PHARMA Scientists & Engineers
  • What is Blockchain BioPharma?
    • Blockchain BioPharma: R&D Origins
      • Harvard Business Review: Why Big Pharma Is Betting on Blockchain
    • 2022 DEV OPS ROADMAP
    • WEDNESDAY, MARCH 16,2022 SPRINT 0: DEMO VIDEO
    • PHARMA INDUSTRY SOLUTIONS: The 80/20 Non-Profit Pharma Company
    • Our Calling for a Pharmaceutical Coalition
    • BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
    • $20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.
    • DAO Mission & Vison
      • Where Will Pharmaceutical eNFT's Come From?
    • Information Architecture Diagram
      • WARNING! ALT-COINS GLOBALLY TARGETED - NEED FOR DEVSECOPS
    • Blockchain BioPharma GAP Analysis
    • Blockchain BioPharma Tokenomics
      • PROPOSED GLOBAL CENTRAL BANK CBDC INTEGRATIONS
      • INTEGRATION POINTS FOR SWIFT & CBDC's
    • BANKING-GRADE SECURITY: SWIFT CODE INTEGRATION
    • Sales & Revenue Model
      • PRODUCT: Quantum SSO
      • PRODUCT: Metaverse Software Apps
      • PRODUCT: eNFT Marketplace for Medicines (Polygon)
        • TYPES OF ENTERPRISE PHARMA eNFT’s:
      • PRODUCT: Metaverse of PHARMA - Introducing CloudLab (VR/AR)
      • SERVICE: Metaverse Development MSP
        • Blockchain BioPharma: MSP Services Rate Card
      • SERVICE: Private-Label IP Monetization (HyperLedger)
      • SERVICE: ENTERPRISE BLOCKCHAIN SMART CONTRACT GAS-FEES
    • What is the Pharmaceutical Token (Ticker: PHARMA)?
      • Are PHARMA Tokens Regulated?
      • Legal Position on the Pharmaceutical Token
      • Using Ethereum Blockchain for Pharmacogenomics Smart Contracts
    • Where Can You Download The Blockchain BioPharma Desktop Applications?
    • What Industries Do We Target?
    • Are PHARMA Tokens on the Cryptocurrency Exchanges?
    • Who Uses The Blockchain BioPharma Application?
    • Does Blockchain BioPharma Loan Money to Drug Developers?
    • Desktop Software Demo
    • Enterprise Pharma eNFT Example
    • Artificial Intelligence & Machine Learning
    • STATE OF THE METAVERSE UNION - Metaverse Market Research
    • Q2 - 2022: Crowdsale
    • Smart Contract Types
    • Competitive Landscape
      • AGILE: Our Competitive Advantage
  • The Competition Justifies our Business Model
    • COMPETITOR #1: Molecule.to
    • COMPETITOR #2: Pharmalyse Finance
  • Get in Touch With Our Community
  • 100% Regulatory and Compliance Transparency
    • Crypto Accounting 101: Price Water House Coopers Regulatory Compliance Opinion
Powered by GitBook
On this page

Was this helpful?

  1. What is Blockchain BioPharma?
  2. DAO Mission & Vison

Where Will Pharmaceutical eNFT's Come From?

What, Where, and How will organizations "Power" our eNFT's for Medicine?

PreviousDAO Mission & VisonNextInformation Architecture Diagram

Last updated 3 years ago

Was this helpful?

INTERNAL DATA & RESEARCH: From an investment perspective, pharmaceutical, life science, and the nutrition industries are booming with no shortage of profitable investments. Our edge will be our R&D Partners, and by purchasing custom pharmaceutical, life, and nutrition science research.

Pharmaceutical Token holders and users will be awarded PHARMA Token for participating in, working on, or submitting projects for us to develop.

UNIVERSITIES: Discoveries in this industry take place at universities, hospitals, by medical doctors, pharmaceutical engineers, industry venture capital and seed investing pitches, and other sources. Colleges will be awarded PHARMA Token for participating in development. Academia is a driver in biopharma. The Community will drive.

THE COALITION: Governments, Pharmaceutical Companies, and Universities, who wish to monetize their IP are What will drive our research experts.

ACCREDITED INVESTORS & ENTERPRISES: Accredited Investors and Intellectual Property holders can monetize via our Enterprise NFT (eNFT) Marketplace for Medicines.

In a "Not Too Soon" Reality, likely 5-Years or Less From now, Quantum Computing, Cloud Computing, Virtual Reality, and Augmented Reality will be the norm for Pharmaceutical Companies to Develop Medicines in the #Metaverse. We aim to begin a concerted effort to #Innovate This "New Normal".